.png){kind=icon}
.png){kind=icon}
Return
Structural Optimization of Cholesteryl ester transfer protein inhibitors: From Early Scaffolds to Advanced Clinical Candidates
.png){kind=icon}
PRE
AI
M
M
M
DOI：10.1016/j.ejmech.2026.118920.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• CETP inhibitors modulate HDL and LDL to reduce cardiovascular risk • Clinical trials reveal mixed efficacy and safety among CETP inhibitors • New-generation CETP inhibitors show improved outcomes and tolerability • Mechanistic insights explain failures of early CETP inhibitor candidates • CETP inhibition remains a promising strategy in lipid management
Keywords:
CETP inhibitors
HDL
LDL
lipid management
clinical trials
Journal
IF:
5.9
Papers:
1.7W
Citations:
6.0W
Organization
Cited Papers